AV, M., V, J., & HT, V. (2019). Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016. Clinical and translational science, 12(4), 361. https://doi.org/10.1111/cts.12617
Chicago Style (17th ed.) CitationAV, Morant, Jagalski V, and Vestergaard HT. "Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016." Clinical and Translational Science 12, no. 4 (2019): 361. https://doi.org/10.1111/cts.12617.
MLA (9th ed.) CitationAV, Morant, et al. "Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non-orphan, Non-oncology Drugs in the European Union and United States from 2012-2016." Clinical and Translational Science, vol. 12, no. 4, 2019, p. 361, https://doi.org/10.1111/cts.12617.